Neurocrine Biosciences: Q3 Earnings Insights

Neurocrine Biosciences (NASDAQ:NBIX) reported its Q3 earnings results on Monday, November 1, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Neurocrine Biosciences reported in-line EPS of $0.64 versus an estimate of $0.6, which did not surprise analysts.

Revenue was up $37,500,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.14, which was followed by a 4.61% drop in the share price the next day.

Here's a look at Neurocrine Biosciences's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.